16
Views
7
CrossRef citations to date
0
Altmetric
Case Reports

First Confirmed Case of Vancomycin-Resistant Enterococcus faecium Meningitis in Turkey:

Pages 608-611 | Published online: 18 Jul 2013

REFERENCES

  • Moellering RC. Enterococcus species, Streptococcus bouis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edn. New York: Churchill Livingstone, 2000: 2147–2156.
  • Edmond MB. Multidrug-resistant enterococci and the threat of vancomycin-resistant Staphylococcus aureus. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 3rd edn. Baltimore: Williams and Wilkins, 1997: 339–355.
  • Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428–442.
  • Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-medi-ated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157–161.
  • Stevenson KB, Murray EW, Sarubbi FA. Enterocoocal meningitis: report of four cases and review. Clin Infect Dis 1994; 18: 233–239.
  • Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB. Group D enterococcal meningitis: clinical and therapeutic considerations with report of three cases and review of the lit-erature. Arch Intern Med 1976; 136: 883–886.
  • Ready LB, Helfer D. Bacterial meningitis in parturients after epidural anesthesia. Anesthesiology 1989; 71: 988–990.
  • Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis suc-cessfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001; 33: 477–482.
  • Fazal BA, Turett GS, Chilimuri SS, Mendoza CM, Telzak EE. Community acquired enterococcal meningitis in an adult. Clin Infect Dis 1995; 20: 725–726.
  • Losonsky GA, Wolf A, Schwalbe RS, Nataro J, Gibson CB, Lewis EW. Successful treatment of meningitis due to mul-tiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis 1994; 19: 163–165.
  • Tush GM, Huneycutt S, Phillips A, Ward JD. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin Infect Dis 1998; 26: 1460–1461.
  • Perez Mato S, Robinson S, Segue RE. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr Infect Dis J 1999; 18: 483–484.
  • Tornieporth NC, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767–772.
  • Eliopoulos GM, Wennersten CB, Gold HS, et al. Characterization of vancomycin-resistant Enterococcus faeci-urn isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother 1998; 42: 1088–1092.
  • Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of van-comycin-resistant enterococcal infections. Clin Infect Dis 1995; 20: 1137–1144.
  • Ricaurte JC, Boucher HW, Turett GS, Moellering RC, Labombardi VJ, Kislak JW. Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. Clin Microbiol Infect 2001; 7: 17–21.
  • Nachman SA, Verma R, Egnor M. Vancomycin-resis-tant Enterococcus faecium shunt infection in an infant: an antibiotic cure. Microb Drug Resist 1995; 1: 95–96.
  • Sarma PS, Mohanty S. Mixed meningitis: association of Acinetobacter calcoaceticus var. !worn and Streptococcus faecium. Postgrad Med J 1995; 71: 295–296.
  • Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 207–209.
  • COCItO C, Di Giambattista M, Nyssen E, Vannuffel P. Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother 1997; 39 (suppl A):7-13.
  • Nachman SA, Phillips A, Gray SL, Talbot CH. Treatment of vancomycin-resistant Enterococcus faecium cen-tral nervous system infection with intrathecal administration of quinupristin-dalfopristin [abstract]. In: Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, Washington, DC: American Society for Microbiology, 1998: 217.
  • Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Treatment of vancomycin-resistant Enterococcus faecium ventricular drain infection with quin-upristin/dalfopristin and review of the literature. J Infect 2000; 41: 95–97.
  • Carey KW, Tesoro E, Muggia V, Pasquier 0, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin/dalfo-pristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis. Pharmacotherapy 200121: 748-750.
  • Williamson JC, Glazier SS, Peacock JE. Successful treatment of ventriculostomy-related meningitis caused by van-comycin-resistant Enterococcus with intravenous and intraven-tricular quinupristin/dalfopristin. Clin Neurol Neurosurg 2002; 104: 54–56.
  • Gransden WR, King A, Marossy D. Quinupristin/dalfo-pristin in neonatal Enterococcus faecium meningitis. Arch Dis Child Fetal Neonatal Ed 1998; 78: F235–236.
  • Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med 2001; 29: 2383–2385.
  • Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and review of the litera-ture. Scand J Infect Dis 2001; 33: 375–379.
  • Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 2001; 20: 432–434.
  • Graham PL, Ampofo K, Saiman L. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 2002; 21: 798–800.
  • Murray BE. Vancomycin-resistant enterococcal infec-tions. N Engl J Med 2000; 342: 710–721.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.